Clinical trials
Phase 2 Cardiotoxicity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Recruiting | 4 |
| Completed | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 2 |
| Avera McKennan Hospital & University Health Center | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Cedars-Sinai Medical Center | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Indiana University | 1 |
| Mayo Clinic | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| National Cancer Institute (NCI) | 1 |
| Rutgers, The State University of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 12 |
| Breast Neoplasms | 8 |
| Lymphoma | 3 |
| Breast Neoplasms, Male | 2 |
| Sarcoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Heart Diseases | 1 |
| Heart Failure | 1 |
| Leukemia | 1 |
| Lung Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.